|Articles|November 19, 2010

Medical Economics, Digital Edition, November 19th, 2010

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics, Digital Edition, November 19th, 2010

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

When a device maker goes dark: What the Boston Scientific cyberattack means for your patients

Amazon Health AI’s digital front door may close the door on independent primary care

No Surprises Act payment dispute process booms to $22.4 billion cost in 4 years: study

Employer health care costs brace for a volatile 2027

11 practice models physicians are using to take back control of the business